Group 1 - The core viewpoint of the report indicates that the pharmaceutical and communication sectors performed well during the period, while the overall market saw declines in major indices [2][8][13] - The report highlights that the average return of actively managed equity funds decreased by 0.26%, while actively managed bond funds saw a slight increase of 0.08% [2][16] - The report notes that the long-term pure bond funds outperformed other bond categories, with an average return of 0.15% for the period [16][17] Group 2 - The report identifies that the pharmaceutical sector has shown strong performance, with several actively managed equity funds focused on this sector achieving high returns [14][15] - The report provides a detailed analysis of various fund categories, indicating that the average return for QDII funds varied significantly, with energy commodity QDII funds leading at 4.54% [18][20] - The report emphasizes that the average return for the equity funds in the Greater China region was notably high at 33.16% for the year [18][20]

Group 1: Report Industry Investment Rating - No relevant content provided Group 2: Core Viewpoints of the Report - A - shares are currently experiencing a normal pull - back during an upward trend and still offer good investment opportunities in sectors like rare earths, artificial intelligence, and innovative drugs. Bond market yields are expected to remain in a narrow low - level range. Gold may continue to rise under Trump's actions and has short - term long - making value [10] Group 3: Summary by Related Catalogs Stock Market - In the past week (20250728 - 20250803), US stocks declined, with the Nasdaq, S&P 500, and Dow Jones Industrial Average changing by - 2.17%, - 2.36%, and - 2.92% respectively. The Nasdaq China Technology Index dropped 3.20%, and the Hang Seng Index fell 3.47% [1] - Most A - share sectors declined. The Wind All - A Index dropped 1.09%. Among different indices, the CSI A100, CSI 300, CSI 500, CSI 1000, CSI 2000, and Wind Micro - cap stocks changed by - 2.15%, - 1.75%, - 1.37%, - 0.54%, - 0.01%, and 1.09% respectively. From a sector style perspective, both blue - chip and growth stocks in the Shanghai and Shenzhen markets declined, and the North - bound 50 Index dropped 2.70% [1] - Most industries declined, with communication and innovative drugs leading the gains. Among 30 CITIC industries, 24 declined and 6 rose. The leading industries were communication and pharmaceuticals, with weekly gains of over 2% [1] Bond Market - In the past week, the price of interest - rate bonds rose, and the yield curve shifted downward. The 10 - year Treasury bond futures main contract rose 0.24% compared to July 25, 2025. The yield of the 10 - year active Treasury bond decreased by 2.65 BP to 1.7059% [1] - The cost of funds decreased. As of August 1, 2025, R007 was 1.4864%, down 20.73 BP from July 25, 2025, and DR007 was 1.4242%, down 22.81 BP. The central bank conducted a net injection of 69 billion yuan in open - market operations last week. In July, the net injection in the repurchase operation was 200 billion yuan, and the Treasury bond trading operation remained at zero [2] - The bond market leverage level declined. The 5 - day average of inter - bank pledged repurchase volume decreased from 7.70 trillion yuan on July 25, 2025, to 6.72 trillion yuan on August 1, 2025 [3] - US Treasury yields declined, and the curve shifted downward. As of August 1, 2025, the 10 - year US Treasury yield decreased by 17 BP to 4.23% compared to July 25, 2025 [4] - The policy of restoring VAT on new - issued Treasury bonds, local government bonds, and financial bonds from August 8, 2025, while keeping existing bonds tax - free until maturity, may lead to a divergence between existing and new bonds. Existing bonds may be favored, and new bonds may require higher yield compensation [6] Foreign Exchange and Commodity Markets - The US dollar appreciated. The US dollar index rose 1.04%. The exchange rates of the US dollar against the euro, pound, and yen changed by 1.33%, 1.18%, and - 0.18% respectively. The exchange rates of the US dollar against the offshore and onshore RMB rose by 0.35% and 0.60% respectively [5] - The price of gold in the domestic market declined. The Shanghai gold spot price dropped 0.89% to 767.29 yuan/gram, and the futures price fell 0.94% to 767.44 yuan/gram. The price of foreign gold had mixed performance [5] Macroeconomic Data - The US non - farm payrolls in July were lower than expected, with 73,000 new jobs, significantly lower than the expected 106,000. The new non - farm payrolls in May and June were revised downwards. The market's expectation of a Fed rate cut in September increased, with the probability rising from 38.4% to 77.7% [7][8] - Trump's order to fire the director of the Bureau of Labor Statistics and the early resignation of a Fed governor have raised concerns about the reliability of employment data and the Fed's independence [9]

Market Overview - A-share market experienced a normal correction with declines of 0.40% and 1.36% on July 30 and 31, 2025, respectively[1] - The bond market showed an upward trend, with 30-year treasury futures rising by 0.47% and 0.57% on the same dates, indicating a stock-bond seesaw effect[2] Economic Factors - Recent US-China trade talks did not yield new agreements, but the market impact is expected to be minimal as tariffs are likely to be extended for 90 days[2] - The Politburo meeting emphasized a proactive fiscal policy and moderate monetary easing, supporting a GDP growth target of 5.0% for the year, which reduces growth pressure for the second half[2] Asset Performance - Major asset classes like cash, bonds, gold, and real estate are underperforming, with bank deposit rates below 1.0% and 10-year treasury yields fluctuating between 1.62% and 1.75%[4][5] - The real estate market shows declining trends, with first-tier cities experiencing a drop in second-hand housing prices and second-tier cities like Nanjing and Xiamen seeing prolonged stagnation[5] Equity Market Insights - The equity market has demonstrated a strong wealth effect, with the Wind ordinary stock fund index rising by 16.18% and QDII funds increasing by 11.85% in 2025[6] - As of July 31, 2025, A-share valuations remain attractive, with average P/E ratios below the 50th percentile of the last 15 years[6] Policy Environment - Continuous policy improvements are enhancing the attractiveness of the A-share market, with recent measures aimed at increasing capital market inclusivity and stability[7] - Initiatives such as the public fund reform and strategies to attract long-term capital are expected to bolster market confidence[7] Future Outlook - The current market correction is viewed as a healthy adjustment within an upward trend, with the potential for the stock market to become a new "wealth anchor" for investors[8] - Given the poor performance of other asset classes, the equity market is positioned to offer better opportunities moving forward[8]

Investment Rating - The report maintains an "Overweight" rating for the communication industry [1][9]. Core Insights - The establishment of China Fusion Energy Co., Ltd. marks a new phase in the development of controllable nuclear fusion, with significant investment from state-owned enterprises totaling 11.492 billion yuan [5][18]. - The investment cycle for controllable nuclear fusion is on the rise, driven by intensified US-China competition and supportive domestic policies [5][18]. - The AI infrastructure expansion and model transition are expected to drive opportunities across the computing and application stack, highlighting the synergy between hardware and software [6][19]. Summary by Sections Market Review - In the past week (July 21-27, 2025), the Shanghai Composite Index and Shenzhen Component Index rose by 1.67% and 2.33%, respectively, while the CITIC Communication Index fell by 0.47%, ranking 28th among 30 primary industries [4][14]. - The top five performing stocks in the communication sector included Dongxin Peace (34.10%), Cheng Tian Wei Ye (17.14%), and Si Nan Navigation (16.54%) [4][15]. Weekly Topic - The focus is on the significant investment in the fusion energy sector by state-owned enterprises, indicating a strategic shift towards large-scale development [5][18]. - The report suggests monitoring related industry chain stocks due to the ongoing investment cycle in controllable nuclear fusion [5][18]. Industry News - China Mobile's centralized procurement for data center switches is expected to involve approximately 33,300 units, with a total budget of about 2.0294 billion yuan [7][21]. - Huawei has the highest share in this procurement, with several other established domestic manufacturers also participating [7][21][23]. Investment Recommendations - The report recommends focusing on key beneficiaries across various sectors, including controllable nuclear fusion and AI-related hardware and software [6][19].

Market Overview - The FOF market has shown growth in both product quantity and scale, with a total of 517 public FOF funds and a total scale of 165.67 billion yuan as of the end of Q2 2025, marking a significant increase from 151.04 billion yuan in the previous quarter [1][5] - In Q2 2025, 14 new FOF funds were established, raising a total of 18.60 billion units, with an average fundraising of 1.33 billion units per fund [1][10] - The number of FOF funds that were liquidated increased to 8 in Q2 2025, up from 4 in the previous quarter [1][16] Performance Analysis - All types of FOF recorded positive returns in Q2 2025, with the average return of the pension target date 2060 fund reaching 3.2% [2][31] - The performance of FOF products varied, with those having a higher equity allocation performing better, while bond-focused FOFs lagged behind with average returns of 1.0% [31][32] Asset Allocation - Public FOFs continued to increase their allocation to bond assets, with the proportion of bond funds rising from 55.68% to 61.93%, while equity fund allocation decreased from 14.30% to 11.35% [3][40] - The equity allocation of flexible allocation mixed FOFs and various pension target risk FOFs slightly decreased, while stock-type FOFs increased their equity allocation significantly from 83.57% to 91.94% [3][42] Fund Issuance and Liquidation - The issuance market for FOFs showed signs of recovery, with 14 new funds launched in Q2 2025, although the number of new funds decreased by 2 compared to the previous quarter [8][10] - The distribution of new FOFs varied significantly by type, with ordinary FOFs being the most prominent, accounting for 10 new funds and raising 16.22 billion units [11][12] Fund Management - The top 10 fund companies managed a total of 101.04 billion yuan in FOFs, representing 60.99% of the total market scale [23][24] - Notable fund companies such as Southern Fund and Oriental Red Asset Management saw significant increases in their FOF management scale due to successful new product launches [23][24] Personal Pension Y Shares - The Y shares of pension FOFs, aimed at individual pension investment, have shown strong growth, with a total scale reaching 10.83 billion yuan, an increase of 630 million yuan from the previous quarter [25][26] Fund Subscription and Redemption - Overall, public FOFs experienced a net redemption of 6.1 billion units in Q2 2025, while Y shares maintained positive net subscriptions, indicating strong market appeal [27][29]

Economic Outlook - The "14th Five-Year Plan" period is crucial for achieving socialist modernization and requires a comprehensive effort to build a new development pattern[3] - Despite complex changes in the development environment, the long-term positive support conditions and basic trends remain unchanged[3] Economic Performance - The economy has shown steady progress this year, with high-quality development achieving new results[4] - There is a recognition of existing risks and challenges, with a shift in focus from external shocks to internal economic stability[4] Policy Recommendations - Maintain policy continuity and stability while enhancing flexibility and foresight, focusing on stabilizing employment, enterprises, markets, and expectations[5] - The government is expected to continue a proactive fiscal policy and moderately loose monetary policy, with an emphasis on increasing the efficiency of government bond issuance[6] Domestic Demand and Investment - There is a call to effectively unleash domestic demand potential, particularly through consumption and investment in key projects[7] - Infrastructure investment is expected to be supported by accelerated government bond issuance and project implementation[7] Reform and Opening Up - Emphasis on deepening reforms and expanding high-level opening up, particularly in technology innovation and international competitiveness[9] - The focus is on stabilizing foreign trade and investment, with measures to support affected enterprises[9] Risk Management - Attention to risk prevention in key areas, including real estate market stabilization and local government debt management[10] - The capital market's attractiveness and inclusivity are to be enhanced to support its recovery[10]

Investment Rating - The report gives a "Buy" rating for the company [3] Core Views - The company is gradually becoming a world-class potash enterprise, focusing on potash as its main business and leveraging its resources in Laos [1][12] - The potash industry is experiencing an upturn, with Laos expected to become a significant source of imports for China [2][35] - The company has ambitious plans to expand its potash production capacity to 5 million tons per year and is also exploring new growth areas such as bromine [2][46] Summary by Sections Company Overview - The company has undergone several transformations, focusing on potash production since acquiring Zhongnong International in 2015 [12] - It has become the largest potash producer in Southeast Asia, with significant resources in Laos [14][16] Potash Industry Analysis - The global potash industry is characterized by oligopoly, with major producers in Canada, Russia, and Belarus [25][29] - Potash demand is expected to grow, driven by population growth and food security concerns [30][34] Production and Expansion Plans - The company aims to achieve a production capacity of 5 million tons of potash per year, with ongoing projects to expand its capacity [44] - The company is also developing bromine production as a complementary business, with significant potential for growth [46][47] Financial Projections - Revenue forecasts for 2025-2027 are projected at 58.35 billion, 79.80 billion, and 98.70 billion yuan, with corresponding net profits of 17.32 billion, 24.50 billion, and 32.13 billion yuan [3][52] - The company is expected to benefit from improved potash prices and increased production capacity [52]

Report Industry Investment Rating - The report indicates a continued optimistic view of the bond market and A-share structural opportunities, but does not explicitly provide a specific industry investment rating [12] Core Viewpoints - The report predicts that the substantial price increases of commodities are driven by the dual positive factors of heightened expectations for supply-side reform and increased demand from the Yarlung Zangbo River Hydropower Project. The bond market is not significantly affected by the commodity price hikes, and the short - term adjustment presents an opportunity to go long on the bond market. In the stock market, the Politburo meeting at the end of July may introduce pro - growth policies, and the upcoming Sino - US economic and trade talks in Sweden are expected to keep investors' risk appetite at a relatively high level. There are still investment opportunities in sectors such as rare earths, artificial intelligence, innovative drugs, and commodities [12] Summary by Related Content Stock Market Performance - **US Stocks**: In the past week (20250721 - 20250727), the Nasdaq, S&P 500, and Dow Jones Industrial Average changed by 1.02%, 1.46%, and 1.26% respectively. The Nasdaq China Technology Index changed by 1.91%, and the Hang Seng Index changed by 2.27% [3] - **A - shares**: The Wind All - A Index rose 2.21%. Among them, the CSI A100, CSI 300, CSI 500, CSI 1000, CSI 2000, and Wind Micro - cap stocks changed by 2.29%, 1.69%, 3.28%, 1.81%, and 3.63% respectively. In terms of sector styles, both blue - chip and growth stocks in the Shanghai and Shenzhen markets rose, with the Shanghai Composite 50 and STAR Market 50 changing by 1.12% and 4.63% respectively, and the Shenzhen Component 100 and ChiNext Index changing by 2.12% and 2.76% respectively. The North Exchange 50 Index changed by 2.85% [4] - **Industry Performance**: Among the 30 CITIC industries, 4 declined and 26 rose. Leading industries included coal, steel, non - ferrous metals, building materials, and construction, with weekly gains exceeding 6%. In terms of ETF performance, rare metals, coal, building materials, non - ferrous metals, and Hong Kong securities performed well, with weekly gains above 7% [4] Bond Market Performance - **Interest - rate Bonds**: In the past week (20250721 - 20250727), the 10 - year Treasury bond futures main contract fell 0.56% compared to July 18, 2025. The yield of the 10 - year active Treasury bond rose 6.72 BP to 1.7324%. Yields of maturities of 6 months and above increased, with longer - term yields rising more, making the yield curve steeper [5] - **Funding Costs**: As of July 25, 2025, R007 was 1.6937%, up 18.65 BP from July 18, 2025, and DR007 was 1.6523%, up 14.56 BP. The spread between them widened. The central bank conducted a net withdrawal of 70.5 billion yuan through open - market operations (reverse repurchase operations and central bank bill swaps) in the past week [6] - **Bond Market Leverage**: The bond market leverage level increased. The 5 - day average of inter - bank pledged repurchase volume increased from 7.24 trillion yuan on July 18, 2025, to 7.70 trillion yuan on July 25, 2025. As of July 25, 2025, the spreads between the yields of 5Y, 10Y, and 30Y Treasury bonds and IRS007 were - 14.52, - 1.76, and 22.25 BP respectively [7] - **US Treasury Bonds**: In the past week (20250721 - 20250727), US Treasury yields showed a pattern of short - term increases and long - term decreases. As of July 25, 2025, the 10 - year US Treasury yield fell 4 BP to 4.40%. Yields of maturities of 3 years and below increased, while those of other maturities decreased, making the yield curve flatter [7][9] Currency and Commodity Markets - **US Dollar**: The US dollar index fell 0.80% in the past week (20250721 - 20250727). The US dollar against the euro, pound, and yen changed by - 1.00%, - 0.19%, and - 0.76% respectively. The US dollar against the offshore and onshore RMB exchange rates fell 0.18% and 0.12% respectively [10] - **Gold**: In the past week (20250721 - 20250727), international gold prices fell, with the London gold spot price down 0.35% to $3343.5 per ounce and the COMEX gold futures price down 0.61% to $3329.1 per ounce. Domestic gold prices rose, with the Shanghai gold spot up 0.09% to 774.21 yuan per gram and the futures up 0.01% to 774.70 yuan per gram [10] Trade Negotiations - The US has reached trade agreements with the Philippines, Japan, and the EU. The US and the EU reached a 15% tariff agreement on July 27, 2025. Sino - US economic and trade talks will be held in Sweden from July 27 - 30, 2025, and their progress is worthy of attention [11]

Report Summary 1. Report Industry Investment Rating No industry investment rating is provided in the report. 2. Core Viewpoints - The industry and market are increasingly focusing on multi - asset ETFs as an innovative product offering one - stop asset allocation solutions. The report explores the development of US multi - asset ETFs to provide insights for domestic market innovation [2][11]. - US multi - asset ETFs have shown significant growth in recent years, with distinct characteristics such as strong head - effects in scale, rapid development of actively managed products, and extensive application of FOF - type products [2][20][31]. - The development of US multi - asset ETFs offers important lessons for the domestic market, including deepening multi - asset index development, diversifying allocation strategies, and broadening underlying asset investment tools [5]. 3. Summary by Directory 3.1 Two Action Plans Mentioned, Multi - asset ETFs Are Approaching - The "Public Offering Plan" emphasizes increasing the creation of asset - allocation products to meet the needs of investors with different risk preferences and promote the coordinated development of equity and fixed - income investments [8]. - The "Index Plan" proposes researching and launching innovative index products such as multi - asset ETFs and expanding the underlying asset categories of ETFs. Recent releases of multi - asset indices indicate growing market attention [10][11]. 3.2 Analysis of the Development History and Current Situation of US Multi - asset ETFs - In 2005, BlackRock issued the world's first multi - asset ETF in Canada. In 2006, Invesco launched the first US multi - asset ETF. After the 2008 financial crisis, multi - asset ETFs evolved rapidly [13][14]. - As of March 31, 2025, there are 181 multi - asset ETFs in the US market, with a total scale of $36 billion, ranking first globally. However, their scale accounts for only 0.35% of all US ETFs, indicating significant growth potential [18]. - The top three fund managers in terms of management scale are BlackRock, Pacer Advisors, and First Trust Portfolios, with a combined scale ratio of 45.35%. The top ten multi - asset ETFs in terms of fund scale account for 51.26% of the total scale [22][25]. - Actively managed multi - asset ETFs have developed rapidly. As of March 31, 2025, 146 out of 181 multi - asset ETFs are actively managed, accounting for 80.66%. Their issuance has increased explosively since 2021 [31]. - FOF - type products are widely used in US multi - asset ETFs. As of March 31, 2025, 73 out of 181 multi - asset ETFs are marked as FOF - type, accounting for nearly 40%, with a fund scale of $13.041 billion, about 36% of the total [34]. - The expense ratios of US multi - asset ETFs vary significantly. The average expense ratio of all 181 multi - asset ETFs is 0.80%, with actively managed and passively managed products having average expense ratios of 0.83% and 0.69% respectively. The expense ratio has generally remained low since 2016 [5][40]. 3.3 Exploration of the Strategy Classification of US Multi - asset ETFs - **Core Allocation Type**: This is the most common strategy type, further divided into target - risk, macro - strategy, and subjective - allocation subtypes. Target - risk type aims to meet pre - designed risk metrics, with 28 products and a scale of $8.176 billion. Macro - strategy type adjusts asset allocation based on macro - economic analysis, with 12 products and a scale of $0.937 billion. Subjective - allocation type gives investment managers high freedom, with 57 products and a scale of $10.402 billion [44][47][51]. - **Trend - Following Type**: These ETFs use momentum factors or trend - following models for asset allocation. As of March 31, 2025, there are 26 products with a scale of $7.193 billion, accounting for about 20% of the total [54][55]. - **Target - Dividend Type**: These ETFs focus on interest (dividend) income, with 22 products and a scale of $6.384 billion. The average historical dividend rate of 17 products issued before 2024 is 7.20%, much higher than other types [58][63]. - **Option - Strategy Type**: These ETFs add option - based derivatives to underlying assets to change the risk - return characteristics. As of March 31, 2025, there are 36 products with a scale of $2.907 billion, accounting for 8.08% of the total [63][64]. 3.4 Suggestions and Insights - **Investor Suggestions**: Different types of investors can choose corresponding multi - asset ETFs. For example, risk - sensitive investors can choose target - risk type; policy - sensitive investors can choose macro - strategy type; investors seeking stable cash flow can choose target - dividend type; those preferring quantitative strategies can choose trend - following type; and investors interested in alternative strategies can choose option - strategy type [68][69][70]. - **Insights for the Domestic Market**: The domestic market should prioritize using existing multi - asset indices as tracking targets, deepen the development of multi - asset indices, focus on stable strategies and diversify allocation strategies, and broaden underlying asset investment tools to promote the development of multi - asset ETFs [72][73][75].

Investment Rating - The industry investment rating is "Overweight (Maintain)" [1] Core Viewpoints - The report highlights that the National Medical Insurance Administration's clarification on not using the lowest price as a reference for centralized procurement is expected to continue promoting and optimizing procurement policies, enhancing the participation of pharmaceutical and medical device companies, and balancing quality and innovation in procurement [7] - LZM012 from Livzon Pharmaceutical has successfully reached its primary research endpoint in Phase III clinical trials, showcasing a dual blockade mechanism that comprehensively inhibits inflammatory responses, providing a new solution for achieving deep clearance of skin lesions and sustained relief [7] Summary by Sections Industry Overview - The report focuses on the pharmaceutical and biotechnology industry, emphasizing the recent developments in centralized procurement and the impact on drug pricing and market dynamics [3][4] Clinical Research Highlights - Livzon Pharmaceutical's LZM012 is the first IL-17A/F dual-target inhibitor to complete Phase III clinical trials in China, demonstrating faster onset and superior efficacy compared to the benchmark drug, Secukinumab [4][6] - Key findings from the clinical trial include: - LZM012 achieved a PASI 75 response rate of 65.7% at week 4, outperforming Secukinumab's 50.3% [4] - At week 12, the PASI 100 response rate for LZM012 was 49.5%, compared to 40.2% for Secukinumab, indicating significant efficacy [4] - Long-term efficacy was sustained, with PASI 100 response rates of 75.9% and 62.6% at week 52 for LZM012 under different dosing regimens, surpassing Secukinumab's 61.6% [4] - Safety profiles were comparable between LZM012 and the control group, with similar rates of adverse events [6] Investment Recommendations - The report suggests focusing on companies such as China National Pharmaceutical Group, Hengrui Medicine, and Livzon Pharmaceutical due to their promising developments and the favorable regulatory environment [7]